1. Home
  2. GDV vs SYRE Comparison

GDV vs SYRE Comparison

Compare GDV & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Dividend & Income Trust of Beneficial Interest

GDV

Gabelli Dividend & Income Trust of Beneficial Interest

HOLD

Current Price

$26.17

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$45.37

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDV
SYRE
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GDV
SYRE
Price
$26.17
$45.37
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$60.13
AVG Volume (30 Days)
105.3K
703.5K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
5.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.10
$10.91
52 Week High
$29.46
$49.31

Technical Indicators

Market Signals
Indicator
GDV
SYRE
Relative Strength Index (RSI) 28.11 59.99
Support Level $24.57 $15.01
Resistance Level $26.76 $45.57
Average True Range (ATR) 0.47 2.38
MACD -0.09 0.21
Stochastic Oscillator 1.20 60.55

Price Performance

Historical Comparison
GDV
SYRE

About GDV Gabelli Dividend & Income Trust of Beneficial Interest

Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, including Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services, and others.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: